Stay updated on APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial
Sign up to get notified when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.

Latest updates to the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a notice that publications are automatically filled from PubMed and that the revision is v3.3.2. Removed the previous notice describing PubMed-sourced publications and the older revision v3.2.0.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoved the banner about government funding status and NIH operating updates; this does not affect the study details or data presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check33 days agoChange DetectedNo significant changes detected; the page content remains the same, with only minor visual differences. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedPage updated to v3.2.0 with a new government-operating status notice; previous version v3.1.0 reference removed. Core content remains, but timing/operational details are updated.SummaryDifference3%

- Check69 days agoChange DetectedThe page mainly updates the version tag to v3.1.0 and removes a prior version tag (v3.0.2); a reference to Dense deposit disease is also removed. No substantive changes to core content, pricing, or key entities are evident.SummaryDifference0.2%

- Check83 days agoChange DetectedUpdated revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' link — a small, mostly UI-focused update.SummaryDifference0.2%

Stay in the know with updates to APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.